Schedule 13D ownership disclosure
Furiex Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 36106P101
Event date: 2014-07-01
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 0.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-14-041530
- Form type
- SC 13D
- Filer
- D. E. Shaw Valence Portfolios, L.L.C.
- CIK
- CIK 1294704
- Filed
- Jul 03, 2014
- Reporting period
- Jul 01, 2014
- Description
- Schedule 13D beneficial ownership